Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations.

Wissmann P, Geisler S, Leblhuber F, Fuchs D.

J Neurol Sci. 2013 Jun 15;329(1-2):29-33. doi: 10.1016/j.jns.2013.03.007. Epub 2013 Apr 6.

PMID:
23566485
2.

Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy.

Zangerle R, Kurz K, Neurauter G, Kitchen M, Sarcletti M, Fuchs D.

Brain Behav Immun. 2010 Mar;24(3):403-8. doi: 10.1016/j.bbi.2009.11.004. Epub 2009 Nov 16.

PMID:
19925861
3.

Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms.

Capuron L, Schroecksnadel S, Féart C, Aubert A, Higueret D, Barberger-Gateau P, Layé S, Fuchs D.

Biol Psychiatry. 2011 Jul 15;70(2):175-82. doi: 10.1016/j.biopsych.2010.12.006. Epub 2011 Jan 31.

PMID:
21277567
4.

Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8.

Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-Unterweger B, Fuchs D.

Cancer Lett. 2008 Dec 8;272(1):141-7. doi: 10.1016/j.canlet.2008.07.002. Epub 2008 Aug 12.

PMID:
18701209
5.

Tryptophan degradation and immune activation in Alzheimer's disease.

Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D.

J Neural Transm (Vienna). 2000;107(3):343-53.

PMID:
10821443
6.

Tryptophan metabolism in post-withdrawal alcohol-dependent patients.

Gleissenthall GV, Geisler S, Malik P, Kemmler G, Benicke H, Fuchs D, Mechtcheriakov S.

Alcohol Alcohol. 2014 May-Jun;49(3):251-5. doi: 10.1093/alcalc/agu011. Epub 2014 Mar 18.

PMID:
24644258
7.

Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults.

Strasser B, Berger K, Fuchs D.

Eur J Nutr. 2015 Feb;54(1):101-7. doi: 10.1007/s00394-014-0690-3. Epub 2014 Apr 1.

PMID:
24687684
8.

Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls.

Schwarz MJ, Guillemin GJ, Teipel SJ, Buerger K, Hampel H.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):345-52. doi: 10.1007/s00406-012-0384-x. Epub 2012 Nov 29.

PMID:
23192697
9.

Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.

Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D.

Clin Sci (Lond). 2009 Apr;116(7):593-8. doi: 10.1042/CS20080319.

PMID:
18986303
10.

Longitudinal study of tryptophan degradation during and after pregnancy.

Schröcksnadel K, Widner B, Bergant A, Neurauter G, Schennach H, Schröcksnadel H, Fuchs D.

Life Sci. 2003 Jan 3;72(7):785-93.

PMID:
12479977
11.

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.

Widner B, Leblhuber F, Fuchs D.

J Neural Transm (Vienna). 2002 Feb;109(2):181-9.

PMID:
12075858
12.

Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.

Frick B, Schroecksnadel K, Neurauter G, Leblhuber F, Fuchs D.

Clin Biochem. 2004 Aug;37(8):684-7.

PMID:
15302611
13.

Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation.

Greilberger J, Fuchs D, Leblhuber F, Greilberger M, Wintersteiger R, Tafeit E.

Clin Lab. 2010;56(9-10):441-8.

PMID:
21086789
14.

High serum tryptophan concentration in pollinosis patients is associated with unresponsiveness to pollen extract therapy.

Kositz C, Schroecksnadel K, Grander G, Schennach H, Kofler H, Fuchs D.

Int Arch Allergy Immunol. 2008;147(1):35-40. doi: 10.1159/000128584. Epub 2008 Apr 30.

PMID:
18446051
15.

Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.

Weinlich G, Murr C, Richardsen L, Winkler C, Fuchs D.

Dermatology. 2007;214(1):8-14.

PMID:
17191041
16.

Tryptophan degradation in patients with gynecological cancer correlates with immune activation.

Schroecksnadel K, Winkler C, Fuith LC, Fuchs D.

Cancer Lett. 2005 Jun 8;223(2):323-9. Epub 2004 Dec 8.

PMID:
15896467
17.

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment.

Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH.

Biol Psychiatry. 2003 Nov 1;54(9):906-14.

PMID:
14573318
18.

Tryptophan degradation and serum neopterin concentrations in intensive care unit patients.

Girgin G, Sahin TT, Fuchs D, Yuksel O, Kurukahvecioglu O, Sare M, Baydar T.

Toxicol Mech Methods. 2011 Mar;21(3):231-5. doi: 10.3109/15376516.2010.545960. Epub 2011 Jan 20.

PMID:
21247367
19.

Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues.

Kohl C, Walch T, Huber R, Kemmler G, Neurauter G, Fuchs D, Sölder E, Schröcksnadel H, Sperner-Unterweger B.

J Affect Disord. 2005 Jun;86(2-3):135-42.

PMID:
15935232
20.

Increased degradation of tryptophan in blood of patients with rheumatoid arthritis.

Schroecksnadel K, Kaser S, Ledochowski M, Neurauter G, Mur E, Herold M, Fuchs D.

J Rheumatol. 2003 Sep;30(9):1935-9.

PMID:
12966593

Supplemental Content

Support Center